"Akathisia, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.
| Descriptor ID |
D017109
|
| MeSH Number(s) |
C10.228.662.037 C10.720.075 C23.888.592.350.600.500 C25.100.249 C25.723.705.100
|
| Concept/Terms |
Akathisia, Drug-Induced- Akathisia, Drug-Induced
- Akathisia, Drug Induced
- Drug-Induced Akathisia
- Drug Induced Akathisia
- Acathisia, Drug-Induced
- Acathisia, Drug Induced
- Drug-Induced Acathisia
|
Below are MeSH descriptors whose meaning is more general than "Akathisia, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Akathisia, Drug-Induced".
This graph shows the total number of publications written about "Akathisia, Drug-Induced" by people in this website by year, and whether "Akathisia, Drug-Induced" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2012 | 1 | 2 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
Below are the most recent publications written about "Akathisia, Drug-Induced" by people in Profiles.
-
Susceptibility to express amphetamine locomotor sensitization correlates with dorsolateral striatum bursting activity and GABAergic synapses in the globus pallidus. Brain Res Bull. 2022 02; 179:83-96.
-
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. Mol Psychiatry. 2019 06; 24(6):795-807.
-
Is LSD toxic? Forensic Sci Int. 2018 Mar; 284:141-145.
-
Correspondence between negative symptoms and potential sources of secondary negative symptoms over time. Eur Arch Psychiatry Clin Neurosci. 2018 Sep; 268(6):603-609.
-
Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice. Int J Neuropsychopharmacol. 2015 Jun 02; 18(11):pyv063.
-
Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015 May 01; 150:1-13.
-
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014 Apr; 44(4):958-64.
-
A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole. Am J Addict. 2014 Sep-Oct; 23(5):475-7.
-
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial. Schizophr Res. 2013 Apr; 145(1-3):101-9.
-
Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use. Am J Alzheimers Dis Other Demen. 2012 Nov; 27(7):468-73.